985 results

... and pulmonary embolism (PE), is one cause of pregnancy-related mortality. Deaths due to PE account for 9.2% of all pregnancy-related deaths or approximately 1.5 deaths per ...

... relatives for genetic counseling purposes. Pregnancy Management No pregnancies have been reported to date in women with SRD. Based on reports that suggest that L-dopa may be advantageous during pregnancy in women with GTP cyclohydrolase 1-deficient dopa- ...

... purposes. Pregnancy Management The use of sirolimus in pregnancy is not recommended due to limited safety data and potential risks to the developing fetus. Animal studies have shown sirolimus to be harmful to the developing ... MotherToBaby for further information on medication use ...

... 17 participants had had discontinued lipid-lowering medications due to pregnancy, lactation, and/or the advice of a physician, ...

... et al 2018 ]. In general, selegiline use during pregnancy is often avoided due to concerns about potential vasoconstrictive effects. One infant in a set of twins exposed to this medication and to levodopa/carbidopa and ... disease during pregnancy was found to have a ventricular septal defect [ ...

... of the possibility of maternal germline mosaicism . To date, sib recurrence due to parental germline mosaicism has not been reported; ...

... CISS/CS may conceive normally. No complications during pregnancy have been reported to date. Treatments for cold-induced sweating (clonidine, amitriptyline, moxonidine) ...

... has been observed during the third trimester of pregnancy [BP Leroy, unpublished observations], possibly due to increased plasma phytanic acid concentration resulting from ...

... 90 persons with EPG5 -related disorder reported to date 1. Either due to or irrespective of gastrointestinal features 2. Note ...

... successful. Screening and management should be up to date prior to pursuing pregnancy. Iron chelation cannot be used during the first ...